Short answer
LifeMD, Inc. (LFMD) filed its Q3 2026 10-Q quarterly report on Nov 12, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $45M (down 24.5% year over year) with net income of −$5M.
Q3 2026 key financials · XBRL
- Revenue
- $45M
- −24.5% YoY · −5.7% QoQ
- Net income
- −$5M
- +5.9% YoY · +34.7% QoQ
- Operating margin
- -10.4%
- Gross margin
- 81.2%
- EPS (diluted)
- −$0.11
- +35.3% QoQ
Source: XBRL data from the LifeMD, Inc. (LFMD) Q3 2026 10-Q on SEC EDGAR. USD.
LifeMD, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $44.6M, down 7% YoY from $47.7M, driven by lower telehealth product demand
- Gross margin 81.51% vs 85.20% YoY, operating margin (10.01)% vs (6.55)%
- Telehealth product revenue weakest, down approximately $3.2M YoY; subscription revenue strongest, up $1.3M over nine months
- Cash $21.9M at September 30, 2026, down $14.9M; operating cash flow used $7.4M vs $11.6M provided YoY
- Outlook: existing cash and Avenue financing expected to fund operations and capital expenditures for at least 12 months; risks include demand and regulatory changes
Risk Factors
- No material changes to risk factors since the December 31, 2025 Form 10-K
- Carried-forward risks could adversely affect business, operating results, and financial condition
- Investment risk remains significant for common-stock purchasers
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other LifeMD, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.